Hemodialysis Use and Practice Patterns: An International Survey Study

医学 血液透析 透析 肾病科 人口 肾脏替代疗法 家庭医学 急诊医学 环境卫生 重症监护医学 内科学
作者
Htay Htay,Aminu K. Bello,Adeera Levin,Meaghan Lunney,Mohamed A. Osman,Feng Ye,Gloria Ashuntantang,Ezequiel Bellorín-Font,Mohammed Benghanem Gharbi,Sara N. Davison,Mohammad Ghnaimat,Paul Harden,Vivekanand Jha,Kamyar Kalantar-Zadeh,Peter G. Kerr,Scott Klarenbach,Csaba P. Kövesdy,Valérie A. Luyckx,Brendon L. Neuen,Dónal O’Donoghue,Shahrzad Ossareh,Jeffrey Perl,Harun Ur Rashid,Éric Rondeau,Emily J See,Syed Saad,Laura Solá,Irma Tchokhonelidze,Vladimı́r Tesař,Kriang Tungsanga,Rümeyza Kazancıoğlu,Angela Yee-Moon Wang,Chih‐Wei Yang,Alexander Zemchenkov,Ming‐Hui Zhao,Kitty J. Jager,Fergus Caskey,Vlado Perkovic,Kailash Jindal,Ikechi G. Okpechi,Marcello Tonelli,David C.H. Harris,David W. Johnson
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:77 (3): 326-335.e1 被引量:16
标识
DOI:10.1053/j.ajkd.2020.05.030
摘要

Rationale & Objective Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. Study Design A cross-sectional survey. Setting & Participants Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. Outcomes Use, availability, accessibility, affordability, and quality of HD care. Analytical Approach Descriptive statistics. Results Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2–9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. Limitations A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. Conclusions In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle–income countries. Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. A cross-sectional survey. Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. Use, availability, accessibility, affordability, and quality of HD care. Descriptive statistics. Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2–9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle–income countries.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
masnoq发布了新的文献求助10
刚刚
1秒前
徐徐完成签到,获得积分10
2秒前
4秒前
4秒前
6秒前
dp_nj发布了新的文献求助10
6秒前
Coatings完成签到,获得积分10
7秒前
8秒前
令狐天与发布了新的文献求助10
8秒前
Hello应助虞莆采纳,获得10
9秒前
cczxhcyh发布了新的文献求助10
10秒前
薇儿发布了新的文献求助10
11秒前
13秒前
zh123发布了新的文献求助10
13秒前
13秒前
14秒前
想你的腋发布了新的文献求助10
15秒前
15秒前
16秒前
16秒前
之_ZH完成签到 ,获得积分10
16秒前
研友_VZG7GZ应助fffzy采纳,获得10
18秒前
非也非也6发布了新的文献求助10
18秒前
可靠发布了新的文献求助10
19秒前
睡前吃太饱了完成签到,获得积分10
19秒前
19秒前
大个应助科研通管家采纳,获得10
19秒前
orixero应助科研通管家采纳,获得10
19秒前
cctv18应助科研通管家采纳,获得10
19秒前
19秒前
19秒前
小马甲应助科研通管家采纳,获得10
19秒前
CipherSage应助科研通管家采纳,获得10
19秒前
今后应助科研通管家采纳,获得10
19秒前
大个应助科研通管家采纳,获得10
19秒前
19秒前
19秒前
20秒前
高分求助中
Thermodynamic data for steelmaking 3000
Teaching Social and Emotional Learning in Physical Education 900
Understanding and Managing Cerebral Aneurysms 800
藍からはじまる蛍光性トリプタンスリン研究 400
Organization Theory and Project Management: Administering Uncertainty in Norwegian Offshore Oil 400
Cardiology: Board and Certification Review 400
[Lambert-Eaton syndrome without calcium channel autoantibodies] 340
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2361252
求助须知:如何正确求助?哪些是违规求助? 2069047
关于积分的说明 5167813
捐赠科研通 1796907
什么是DOI,文献DOI怎么找? 897668
版权声明 557675
科研通“疑难数据库(出版商)”最低求助积分说明 479154